Financial Ratios Align Technology, Inc.
Equities
ALGN
US0162551016
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 168.78 USD | +0.23% |
|
-5.66% | +8.09% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 11.33 | 6.91 | 6.83 | 6.87 | 6.94 | |||||
Return on Total Capital | 17.27 | 10.98 | 10.98 | 10.93 | 10.62 | |||||
Return On Equity % | 22.52 | 10.01 | 12.31 | 11.26 | 10.39 | |||||
Return on Common Equity | 22.52 | 10.01 | 12.31 | 11.26 | 10.39 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 74.26 | 70.6 | 70.1 | 70.09 | 69.81 | |||||
SG&A Margin | 43.23 | 44.84 | 44.1 | 44.09 | 43.51 | |||||
EBITDA Margin % | 27.45 | 20.96 | 20.71 | 20.52 | 21.1 | |||||
EBITA Margin % | 25.12 | 18.02 | 17.44 | 17.37 | 17.59 | |||||
EBIT Margin % | 24.7 | 17.59 | 17.02 | 16.89 | 17.12 | |||||
Income From Continuing Operations Margin % | 19.53 | 9.68 | 11.52 | 10.54 | 10.17 | |||||
Net Income Margin % | 19.53 | 9.68 | 11.52 | 10.54 | 10.17 | |||||
Net Avail. For Common Margin % | 19.53 | 9.68 | 11.52 | 10.54 | 10.17 | |||||
Normalized Net Income Margin | 15.32 | 10.26 | 10.68 | 10.42 | 11.03 | |||||
Levered Free Cash Flow Margin | 15.07 | 7.33 | 16 | 15.52 | 11.99 | |||||
Unlevered Free Cash Flow Margin | 15.07 | 7.33 | 16 | 15.52 | 11.99 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.73 | 0.63 | 0.64 | 0.65 | 0.65 | |||||
Fixed Assets Turnover | 3.91 | 2.92 | 2.8 | 2.86 | 3.08 | |||||
Receivables Turnover (Average Receivables) | 5.08 | 4.25 | 4.38 | 4.21 | 3.85 | |||||
Inventory Turnover (Average Inventory) | 5.51 | 3.86 | 3.63 | 4.34 | 5.07 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.3 | 1.26 | 1.18 | 1.22 | 1.36 | |||||
Quick Ratio | 1.08 | 1.04 | 0.98 | 1.02 | 1.17 | |||||
Operating Cash Flow to Current Liabilities | 0.61 | 0.3 | 0.38 | 0.36 | 0.31 | |||||
Days Sales Outstanding (Average Receivables) | 71.79 | 85.85 | 83.31 | 86.91 | 94.87 | |||||
Days Outstanding Inventory (Average Inventory) | 66.29 | 94.57 | 100.47 | 84.33 | 71.99 | |||||
Average Days Payable Outstanding | 50.39 | 44.13 | 39.52 | 35.19 | 35.28 | |||||
Cash Conversion Cycle (Average Days) | 87.68 | 136.3 | 144.25 | 136.05 | 131.58 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 3.46 | 3.52 | 3.49 | 3.1 | 2.83 | |||||
Total Debt / Total Capital | 3.34 | 3.4 | 3.37 | 3 | 2.75 | |||||
LT Debt/Equity | 2.83 | 2.79 | 2.67 | 2.29 | 2.04 | |||||
Long-Term Debt / Total Capital | 2.74 | 2.69 | 2.58 | 2.22 | 1.98 | |||||
Total Liabilities / Total Assets | 39.03 | 39.45 | 40.33 | 38.02 | 35.04 | |||||
Total Debt / EBITDA | 0.11 | 0.15 | 0.15 | 0.14 | 0.13 | |||||
Net Debt / EBITDA | -1.04 | -1.09 | -0.99 | -1.07 | -1.09 | |||||
Total Debt / (EBITDA - Capex) | 0.17 | 0.23 | 0.19 | 0.16 | 0.14 | |||||
Net Debt / (EBITDA - Capex) | -1.61 | -1.66 | -1.25 | -1.23 | -1.23 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 59.9 | -5.51 | 3.42 | 3.54 | 0.9 | |||||
Gross Profit, 1 Yr. Growth % | 66.48 | -10.18 | 2.8 | 3.52 | 0.55 | |||||
EBITDA, 1 Yr. Growth % | 125.74 | -27.87 | 2.55 | 2.61 | 3.97 | |||||
EBITA, 1 Yr. Growth % | 147.9 | -32.24 | 0.55 | 3.07 | 2.45 | |||||
EBIT, 1 Yr. Growth % | 152.19 | -32.72 | 0.51 | 2.77 | 2.54 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -56.53 | -53.17 | 23.09 | -5.32 | -2.61 | |||||
Net Income, 1 Yr. Growth % | -56.53 | -53.17 | 23.09 | -5.32 | -2.61 | |||||
Normalized Net Income, 1 Yr. Growth % | 149.01 | -36.7 | 8.14 | 1.01 | 7.1 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -56.76 | -52.43 | 26.03 | -3.27 | 0.53 | |||||
Accounts Receivable, 1 Yr. Growth % | 36.41 | -4.18 | 5.09 | 10.21 | 10.65 | |||||
Inventory, 1 Yr. Growth % | 65.35 | 47.14 | -12.35 | -14.35 | -10.99 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 47.22 | 12.26 | 4.3 | -1.73 | -10.45 | |||||
Total Assets, 1 Yr. Growth % | 23.03 | 0.1 | 2.29 | 2.15 | 0.31 | |||||
Tangible Book Value, 1 Yr. Growth % | 16.38 | 0.12 | 0.99 | 5.66 | 4.76 | |||||
Common Equity, 1 Yr. Growth % | 12.02 | -0.59 | 0.81 | 6.1 | 5.12 | |||||
Cash From Operations, 1 Yr. Growth % | 77.07 | -51.5 | 38.16 | -6.05 | -19.64 | |||||
Capital Expenditures, 1 Yr. Growth % | 158.91 | -27.22 | -39.12 | -34.96 | -11.36 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 18.24 | -54.05 | 127.32 | 0.42 | -21.94 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 18.24 | -54.05 | 127.32 | 0.42 | -21.94 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 28.15 | 22.92 | -1.15 | 3.48 | 2.21 | |||||
Gross Profit, 2 Yr. CAGR % | 29.74 | 22.28 | -3.96 | 3.16 | 2.01 | |||||
EBITDA, 2 Yr. CAGR % | 35.22 | 27.6 | -14.15 | 2.58 | 3.22 | |||||
EBITA, 2 Yr. CAGR % | 38.14 | 29.61 | -17.63 | 1.81 | 2.69 | |||||
EBIT, 2 Yr. CAGR % | 37.76 | 30.26 | -17.95 | 1.63 | 2.58 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 32.05 | -54.88 | -24.07 | 7.95 | -3.98 | |||||
Net Income, 2 Yr. CAGR % | 32.05 | -54.88 | -24.07 | 7.95 | -3.98 | |||||
Normalized Net Income, 2 Yr. CAGR % | 37.66 | 25.54 | -17.46 | 4.52 | 3.93 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 32.37 | -54.64 | -22.57 | 10.41 | -1.39 | |||||
Accounts Receivable, 2 Yr. CAGR % | 27.69 | 14.33 | 0.35 | 7.62 | 10.43 | |||||
Inventory, 2 Yr. CAGR % | 43.34 | 55.98 | 13.56 | -13.36 | -12.69 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 32.25 | 28.56 | 8.21 | 1.24 | -6.19 | |||||
Total Assets, 2 Yr. CAGR % | 54.15 | 10.97 | 1.19 | 2.22 | 1.22 | |||||
Tangible Book Value, 2 Yr. CAGR % | 56.07 | 7.94 | 0.55 | 3.3 | 5.21 | |||||
Common Equity, 2 Yr. CAGR % | 64.05 | 5.53 | 0.11 | 3.42 | 5.61 | |||||
Cash From Operations, 2 Yr. CAGR % | 25.26 | -7.32 | -18.14 | 13.93 | -13.11 | |||||
Capital Expenditures, 2 Yr. CAGR % | 63.68 | 37.27 | -33.44 | -37.07 | -24.08 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 21.35 | -26.29 | 1.87 | 51.08 | -11.51 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 21.35 | -26.29 | 1.87 | 51.08 | -11.51 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 26.2 | 15.77 | 16.04 | 0.39 | 2.61 | |||||
Gross Profit, 3 Yr. CAGR % | 26.56 | 14.77 | 15.37 | -1.53 | 2.26 | |||||
EBITDA, 3 Yr. CAGR % | 27.68 | 9.66 | 18.49 | -8.89 | 2.97 | |||||
EBITA, 3 Yr. CAGR % | 28.08 | 8.95 | 18.93 | -11.24 | 1.94 | |||||
EBIT, 3 Yr. CAGR % | 27.91 | 8.49 | 19.3 | -11.55 | 1.84 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 24.48 | -6.53 | -36.95 | -18.28 | 4.31 | |||||
Net Income, 3 Yr. CAGR % | 24.48 | -6.53 | -36.95 | -18.28 | 4.31 | |||||
Normalized Net Income, 3 Yr. CAGR % | 28.38 | 6.25 | 19.27 | -11.71 | 5.28 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 25.35 | -5.89 | -36.24 | -16.61 | 7.02 | |||||
Accounts Receivable, 3 Yr. CAGR % | 26.9 | 16.03 | 11.16 | 3.53 | 8.62 | |||||
Inventory, 3 Yr. CAGR % | 60.54 | 44.6 | 28.71 | 3.37 | -12.58 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 32.15 | 25.22 | 19.9 | 4.79 | -2.82 | |||||
Total Assets, 3 Yr. CAGR % | 42.52 | 33.49 | 8 | 1.51 | 1.58 | |||||
Tangible Book Value, 3 Yr. CAGR % | 38.26 | 34.6 | 5.57 | 2.23 | 3.79 | |||||
Common Equity, 3 Yr. CAGR % | 42.46 | 38.82 | 3.93 | 2.07 | 3.98 | |||||
Cash From Operations, 3 Yr. CAGR % | 28.34 | -8.7 | 5.87 | -14.29 | 1.42 | |||||
Capital Expenditures, 3 Yr. CAGR % | 21.56 | 24.93 | 4.68 | -33.95 | -29.46 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 32.6 | -12.21 | 7.06 | 1.38 | 21.16 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 32.6 | -12.21 | 7.06 | 1.38 | 21.16 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 29.63 | 20.44 | 14.45 | 10.69 | 10.3 | |||||
Gross Profit, 5 Yr. CAGR % | 29.2 | 18.74 | 13.34 | 9.96 | 9.82 | |||||
EBITDA, 5 Yr. CAGR % | 31.48 | 14.51 | 8.94 | 6.7 | 12.11 | |||||
EBITA, 5 Yr. CAGR % | 31.54 | 13.34 | 7.35 | 5.94 | 12.12 | |||||
EBIT, 5 Yr. CAGR % | 31.44 | 13.19 | 7.1 | 5.6 | 12.28 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 32.41 | 9.34 | 2.15 | -0.99 | -25.4 | |||||
Net Income, 5 Yr. CAGR % | 32.41 | 9.34 | 2.15 | -0.99 | -25.4 | |||||
Normalized Net Income, 5 Yr. CAGR % | 32.1 | 11.15 | 7.59 | 5.46 | 12.85 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 32.98 | 10.25 | 3.38 | 0.32 | -24.09 | |||||
Accounts Receivable, 5 Yr. CAGR % | 29.39 | 21.54 | 15.53 | 12.59 | 10.87 | |||||
Inventory, 5 Yr. CAGR % | 53.37 | 60.62 | 39.78 | 17.81 | 10.21 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 47.02 | 31.1 | 22 | 15.01 | 8.69 | |||||
Total Assets, 5 Yr. CAGR % | 33.6 | 27.23 | 24.27 | 19.97 | 5.24 | |||||
Tangible Book Value, 5 Yr. CAGR % | 27.64 | 23.8 | 21.72 | 21.08 | 5.43 | |||||
Common Equity, 5 Yr. CAGR % | 29.48 | 25.55 | 23.71 | 23.4 | 4.6 | |||||
Cash From Operations, 5 Yr. CAGR % | 36.48 | 5.34 | 7.21 | -0.24 | -2.18 | |||||
Capital Expenditures, 5 Yr. CAGR % | 41.55 | 8.33 | -4.46 | -5.04 | -7.94 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 33.4 | 12.82 | 19.33 | 8.94 | -0.81 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 33.4 | 12.82 | 19.33 | 8.94 | -0.81 |
- Stock Market
- Equities
- ALGN Stock
- Financials Align Technology, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















